Aardvark Therapeutics, Inc. (AARD)
Nasdaq: AARD · CIK 0001774857 · United States
Every official Aardvark Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AARD filings
Aardvark Therapeutics, Inc. documents
- Aardvark Therapeutics, Inc. 10-K 2026AARD 10-K 2026: annual report for fiscal 2026
- Aardvark Therapeutics, Inc. 10-K 2025AARD 10-K 2025: annual report for fiscal 2025
- Aardvark Therapeutics, Inc. 10-K 2024AARD 10-K 2024: annual report for fiscal 2024
- Aardvark Therapeutics, Inc. 10-K 2023AARD 10-K 2023: annual report for fiscal 2023
- Aardvark Therapeutics, Inc. 10-K 2022AARD 10-K 2022: annual report for fiscal 2022
- Aardvark Therapeutics, Inc. 10-Q 2026AARD 10-Q 2026: quarterly report for fiscal 2026
- Aardvark Therapeutics, Inc. 10-Q 2025AARD 10-Q 2025: quarterly report for fiscal 2025
- Aardvark Therapeutics, Inc. 10-Q 2024AARD 10-Q 2024: quarterly report for fiscal 2024
- Aardvark Therapeutics, Inc. 10-Q 2023AARD 10-Q 2023: quarterly report for fiscal 2023
- Aardvark Therapeutics, Inc. 10-Q 2022AARD 10-Q 2022: quarterly report for fiscal 2022
- Aardvark Therapeutics, Inc. 8-K 2026AARD 8-K 2026: current report for fiscal 2026
- Aardvark Therapeutics, Inc. 8-K 2025AARD 8-K 2025: current report for fiscal 2025
- Aardvark Therapeutics, Inc. 8-K 2024AARD 8-K 2024: current report for fiscal 2024
- Aardvark Therapeutics, Inc. 8-K 2023AARD 8-K 2023: current report for fiscal 2023
- Aardvark Therapeutics, Inc. 8-K 2022AARD 8-K 2022: current report for fiscal 2022
- Aardvark Therapeutics, Inc. DEF 14A 2026AARD DEF 14A 2026: proxy statement for fiscal 2026
- Aardvark Therapeutics, Inc. DEF 14A 2025AARD DEF 14A 2025: proxy statement for fiscal 2025
- Aardvark Therapeutics, Inc. DEF 14A 2024AARD DEF 14A 2024: proxy statement for fiscal 2024
- Aardvark Therapeutics, Inc. DEF 14A 2023AARD DEF 14A 2023: proxy statement for fiscal 2023
- Aardvark Therapeutics, Inc. DEF 14A 2022AARD DEF 14A 2022: proxy statement for fiscal 2022
- Aardvark Therapeutics, Inc. Form 4 2026AARD Form 4 2026: insider trading filing for fiscal 2026
- Aardvark Therapeutics, Inc. Form 4 2025AARD Form 4 2025: insider trading filing for fiscal 2025
- Aardvark Therapeutics, Inc. Form 4 2024AARD Form 4 2024: insider trading filing for fiscal 2024
- Aardvark Therapeutics, Inc. Form 4 2023AARD Form 4 2023: insider trading filing for fiscal 2023
- Aardvark Therapeutics, Inc. Form 4 2022AARD Form 4 2022: insider trading filing for fiscal 2022
- Aardvark Therapeutics, Inc. S-1 2026AARD S-1 2026: registration statement for fiscal 2026
- Aardvark Therapeutics, Inc. S-1 2025AARD S-1 2025: registration statement for fiscal 2025
- Aardvark Therapeutics, Inc. S-1 2024AARD S-1 2024: registration statement for fiscal 2024
- Aardvark Therapeutics, Inc. S-1 2023AARD S-1 2023: registration statement for fiscal 2023
- Aardvark Therapeutics, Inc. S-1 2022AARD S-1 2022: registration statement for fiscal 2022
- Aardvark Therapeutics, Inc. 13F 2026AARD 13F 2026: institutional holdings for fiscal 2026
- Aardvark Therapeutics, Inc. 13F 2025AARD 13F 2025: institutional holdings for fiscal 2025
- Aardvark Therapeutics, Inc. 13F 2024AARD 13F 2024: institutional holdings for fiscal 2024
- Aardvark Therapeutics, Inc. 13F 2023AARD 13F 2023: institutional holdings for fiscal 2023
- Aardvark Therapeutics, Inc. 13F 2022AARD 13F 2022: institutional holdings for fiscal 2022
More companies